Primary navigation

    Solodyn

    Drug - Solodyn (minocycline)

    August 2008

    Therapeutic Area - Acne Vulgaris

    FDA approved indication

    Solodyn™ is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Solodyn did not demonstrate any effect on non-inflammatory lesions. Safety of Solodyn has not been established beyond 12 weeks of use.

    Criteria

    • Patient is 12 years of age or older AND
    • Is being treated for moderate to severe acne vulgaris AND
    • Has tried two other oral antibiotics intended for acne treatment, one of which must be a generic minocycline

    Rationale

    Solodyn is priced at $19 per tablet. There are no studies showing its comparative effectiveness to generic monocycline. Generic minocycline is priced at about 25 cents to 40 cents per dosage form.

    Questions?

    MHCP Provider Call Center 651-431-2700 or 800-366-5411

    back to top